A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

This follows an extensive review that found the drug ineffective for treating nasal congestion. Oral phenylephrine, widely ...

demonstrated a statistically significant and clinically meaningful reduction in the size of nasal polyps and reduced nasal congestion compared to placebo. WAYPOINT is a randomized, double-blind trial ...

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...

Sinus infections (also known as sinusitis) strike more than 30 million Americans each year. And if you’re one of them, you’re ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency says a common ingredient they share, phenylephrine, doesn’t actually relieve ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...